Related Experiment Video
Updated: Apr 4, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling
Clare Stretton1, Thorsten M Hoffmann1, Michael J Munson2
1Division of Cell Signalling & Immunology, James Black Centre, College of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Abstract:
The mammalian or mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) is a ubiquitously expressed multimeric protein kinase complex that integrates nutrient and growth factor signals for the co-ordinated regulation of cellular metabolism and cell growth. Herein, we demonstrate that suppressing the cellular activity of glycogen synthase kinase-3 (GSK3), by use of pharmacological inhibitors or shRNA-mediated gene silencing, results in substantial reduction in amino acid (AA)-regulated mTORC1-directed signalling, as assessed by phosphorylation of multiple downstream mTORC1 targets. We show that GSK3 regulates mTORC1 activity through its ability to phosphorylate the mTOR-associated scaffold protein raptor (regulatory-associated protein of mTOR) on Ser(859). We further demonstrate that either GSK3 inhibition or expression of a S859A mutated raptor leads to reduced interaction between mTOR and raptor and under these circumstances, irrespective of AA availability, there is a consequential loss in phosphorylation of mTOR substrates, such as p70S6K1 (ribosomal S6 kinase 1) and uncoordinated-51-like kinase (ULK1), which results in increased autophagic flux and reduced cellular proliferation.
Insights
Inhibiting glycogen synthase kinase-3 (GSK3) reduces amino acid-regulated mTORC1 signaling by affecting raptor phosphorylation. This impacts cellular metabolism, leading to increased autophagy and reduced cell growth.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Mammalian or mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) is a key regulator of cellular metabolism and growth.
- mTORC1 integrates nutrient and growth factor signals to control these processes.
Purpose of the Study:
- To investigate the role of glycogen synthase kinase-3 (GSK3) in regulating mTORC1 signaling.
- To identify the mechanism by which GSK3 influences mTORC1 activity.
Main Methods:
- Pharmacological inhibition and shRNA-mediated gene silencing of GSK3.
- Assessment of mTORC1 signaling by measuring phosphorylation of downstream targets.
- Analysis of raptor phosphorylation at Serine 859 (Ser859).
- Investigation of mTOR-raptor interaction and substrate phosphorylation.
Main Results:
- GSK3 suppression significantly reduces amino acid-regulated mTORC1 signaling.
- GSK3 phosphorylates raptor on Ser859, a key regulatory site.
- GSK3 inhibition or S859A raptor mutation decreases mTOR-raptor interaction.
- Reduced mTOR-raptor interaction leads to decreased phosphorylation of p70S6K1 and ULK1, increasing autophagic flux and reducing cell proliferation.
Conclusions:
- GSK3 is a crucial regulator of amino acid-dependent mTORC1 signaling.
- GSK3's phosphorylation of raptor at Ser859 is a critical step in mTORC1 activation.
- Targeting GSK3 offers a potential strategy to modulate mTORC1 activity, autophagy, and cell proliferation.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway

